These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6829183)

  • 41. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components.
    Saarinen UM; Kekomäki R; Siimes MA; Myllylä G
    Blood; 1990 Jan; 75(2):512-7. PubMed ID: 2295005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
    Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
    Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The in vitro evaluation of two filters (Erypur and Imugard IG 500) for white cell-poor platelet concentrates.
    Brubaker DB; Romine CM
    Transfusion; 1988; 28(4):383-5. PubMed ID: 3388485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of white cell reduction in red cell concentrates by filtration: the effect of the cellular composition of the red cell concentrates.
    Steneker I; Prins HK; Florie M; Loos JA; Biewenga J
    Transfusion; 1993 Jan; 33(1):42-50. PubMed ID: 8424266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
    Gmür J; Burger J; Sauter C; Oelz O; Frick PG
    Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
    [No Abstract]   [Full Text] [Related]  

  • 47. Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats.
    Novotny VM; van Doorn R; Rozier Y; D'Amaro J; Harvey MS; Brand A
    Vox Sang; 1992; 63(1):23-30. PubMed ID: 1413660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Provision of leucocyte poor blood at the bedside.
    MacNamara E; Clarke S; McCann SR
    J Clin Pathol; 1984 Jun; 37(6):669-72. PubMed ID: 6725612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
    Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Filtration of platelet concentrates. Technical aspects, quantitative results. Group PSL].
    Shonneman F
    Rev Fr Transfus Hemobiol; 1993 Jun; 36(3):253-64. PubMed ID: 8347250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biologic effects of leukocytes present in transfused cellular blood products.
    Bordin JO; Heddle NM; Blajchman MA
    Blood; 1994 Sep; 84(6):1703-21. PubMed ID: 8080981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In-line leukocyte depletion ov thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():110-3. PubMed ID: 9417333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
    Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.
    Seftel MD; Growe GH; Petraszko T; Benny WB; Le A; Lee CY; Spinelli JJ; Sutherland HJ; Tsang P; Hogge DE
    Blood; 2004 Jan; 103(1):333-9. PubMed ID: 12958065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Removal of leucocytes from whole blood and erythrocyte suspensions by filtration through cotton wool. IV. Immunization studies in rabbits.
    Engelfriet CP; Diepenhorst P; Van den Giessen M; von Riesz E
    Vox Sang; 1975; 28(2):81-9. PubMed ID: 1114794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new radioimmunoassay for the detection of small amounts of white cells and platelets in red cell concentrates: implications for blood transfusion.
    Webster MR; Prins HK; Huisman JG
    Transfusion; 1990 Feb; 30(2):117-25. PubMed ID: 2305440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
    Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
    Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preparation of leukocyte-depleted thrombocyte concentrate: in-vitro testing of a new filtration system (PL 100)].
    Böck M; Himmelsbach S; Gudden A; Greither L; Mempel W
    Infusionstherapie; 1991 Feb; 18(1):30-2. PubMed ID: 2030050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation of random donor leukocyte-poor platelets by cytapheresis.
    Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
    Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.